Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bicycle Therapeutics Limited

7.28
+0.18002.54%
Volume:637.23K
Turnover:4.58M
Market Cap:504.17M
PE:-2.32
High:7.35
Open:7.13
Low:7.03
Close:7.10
Loading ...

Bicycle Therapeutics Plc: Felix J. Baker to Become Chairman of Board of Directors

THOMSON REUTERS
·
27 Mar

Bicycle Therapeutics Announces New Board and Key Clinical Leadership Appointments

Business Wire
·
27 Mar

European Equities Traded in the US as American Depositary Receipts Track Higher in Monday Trading

MT Newswires Live
·
17 Mar

Bicycle Therapeutics Price Target Maintained With a $30.00/Share by Needham

Dow Jones
·
11 Mar

European Equities Traded in the US as American Depositary Receipts Surge Higher in Monday Trading

MT Newswires Live
·
04 Mar

BRIEF-Eckert & Ziegler Enters Partnership With Bicycle Therapeutics

Reuters
·
27 Feb

Stock Track | Bicycle Therapeutics Surges 5.23% After Narrower FY 2024 Loss, Strong Revenue Growth

Stock Track
·
26 Feb

Barclays Remains a Buy on Bicycle Therapeutics (BCYC)

TIPRANKS
·
26 Feb

Bicycle Therapeutics Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.
·
26 Feb

Bicycle Therapeutics Plc : Jefferies Cuts Target Price to $42 From $53

THOMSON REUTERS
·
26 Feb

TD Cowen Keeps Their Buy Rating on Bicycle Therapeutics (BCYC)

TIPRANKS
·
26 Feb

Bicycle Therapeutics PLC reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
25 Feb

Bicycle Therapeutics Q4 2024 GAAP EPS $(0.75) Beats $(0.87) Estimate, Cash And Cash Equivalents Of $879.5M As Of December 31, 2024, Expected To Provide Financial Runway Into 2H 2027

Benzinga
·
25 Feb

Bicycle Therapeutics Q4 Operating Incom USD -67.663 Million

THOMSON REUTERS
·
25 Feb

Bicycle Therapeutics Plc: Cash and Cash Equivalents of $879.5 Mln as of Dec 31, 2024, Expected to Provide Financial Runway Into 2H 2027

THOMSON REUTERS
·
25 Feb

Bicycle Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2024 Financial Results

Business Wire
·
25 Feb

Bicycle Therapeutics (BCYC): Among The Small–Cap Stocks Insiders Are Selling Recently

Insider Monkey
·
15 Feb

Bicycle Therapeutics PLC expected to post a loss of 86 cents a share - Earnings Preview

Reuters
·
14 Feb

European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading

MT Newswires Live
·
12 Feb

Bicycle Therapeutics (NASDAQ:BCYC) shareholders have endured a 74% loss from investing in the stock three years ago

Simply Wall St.
·
05 Feb